JPRN-UMIN000014498招募中1 期
Phase I/II study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemoradiationtherapy for borderline resectable pancreatic cancer (Prep-03/NS014-1) - Neoadjuvant GS chemoradationtherapy for borderline resectable pancreatic cancer : Prep-03/NS014-1
Study group of preoperative therapy for pancreatic cancer (PREP)0 个研究点目标入组 40 人开始时间: 2014年7月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) pulmonary fibrosis or interstitial pneumonitis 2) Active double cancer 3) Active infection 4) HBs antigen positive 5) patients are using flucytosine, phenytoin, warfarin 6) pregnant females, possibly pregnant females
研究者
相似试验
招募中
1 期
Prep-03C535836Pancreatic cancerpancreatic cancerJPRN-jRCTs021180045nno Michiaki40
已完成
2 期
Phase II/III study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemotherapy for resectable pancreatic cancer (Prep-02/JSAP-05)JPRN-UMIN000009634Study group of preoperative therapy for pancreatic cancer (PREP)/Japanese Study Group of Adjuvant Therapy for pancreatic Cancer (JSAP)364
已完成
2 期
Phase II study of gemcitabine/S-1 combination therapy in patients with non-resectable advanced biliary tract cancernon-resectable biliary tract cancer or recurrent biliary tract cancer post surgical treatmentJPRN-UMIN000000792Kyoto University Hospital25
已完成
2 期
Phase II study of gemcitabine and S-1 combination therapy in advanced pancreatic cancer with malignant ascites.pancreatic cancer with ascitesJPRN-UMIN000003269ational Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division36
已完成
2 期
Randomized phase II study of Gemcitabine and S-1 combination therapy versus S-1 in patients with Gemcitabine-refractory unresectable advanced Pancreatic Cancerunresectable advanced Pancreatic CancerJPRN-UMIN000011806Osaka Pancreas Forum49